Evidence map›Paper›PMID 34835962›Full record

ReviewNutrients2021

Yerba Mate-A Long but Current History.

Anna Gawron-Gzella, Justyna Chanaj-Kaczmarek, Judyta Cielecka-Piontek

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 99 citations in OpenAlex.

  1. Nutrients · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rejuvenation of MaturePlants (Basel, Switzerland) · 2025
    Article
  10. Yerba Mate (Nutrients · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. A sustainable integrated agroforestry system.Frontiers in plant science · 2025
    Article
  15. Article
  16. Review
  17. Antioxidant Scavenging of the Superoxide Radical by Yerba Mate (International journal of molecular sciences · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anna Gawron-GzellaDepartment of Pharmacognosy, Faculty of Pharmacy, Poznan University of Medical Sciences, 4 Swiecickiego Street, 61-781 Poznan, Poland.ORCID 0000-0002-7409-0489
Justyna Chanaj-KaczmarekDepartment of Pharmacognosy, Faculty of Pharmacy, Poznan University of Medical Sciences, 4 Swiecickiego Street, 61-781 Poznan, Poland.ORCID 0000-0001-8892-1450
Judyta Cielecka-PiontekDepartment of Pharmacognosy, Faculty of Pharmacy, Poznan University of Medical Sciences, 4 Swiecickiego Street, 61-781 Poznan, Poland.ORCID 0000-0003-0891-5419
Poznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bearing in mind the growing interest in Yerba Mate, a comprehensive study has been prepared containing the most important aspects and possibilities of its use. The introduction of the work contains the species characteristics of Yerba Mate, as well as information about the origin and places of cultivation. The next part focuses on the analysis of the composition, pointing to purine alkaloids, polyphenols, saponins, and minerals as groups of active compounds responsible for the clinical activity of Yerba Mate. The review of the results of preclinical and clinical studies indicates activity in relation to the stimulating effect, reducing weight by stimulating lipolysis, cardioprotective, anti-diabetic, and anti-inflammatory effects. The information about the action of Yerba Mate is supplemented by the characteristics of its potential toxicity in terms of PAHs content (in particular benzo[α]pyrene) and preparation as a determinant of increased irritation. The current data on the effects of Yerba Mate and the wide safety margin of its use position this raw material as a valuable component of functional food. The growing frequency of consuming Yerba Mate, conditioned by the availability resulting from the globalization of the market and the information provided about it's the pro-health effects, will position Yerba Mate's popularity among wider population groups.

Indexed as

AnimalsAntioxidantsCardiotonic AgentsFunctional FoodHumansIlex paraguariensisLipid MetabolismPhytochemicalsAntioxidantsCardiotonic AgentsPhytochemicalsactive compoundsbiological activityfunctional foodpotential toxicityYerba Mate

Identifiers

PMID34835962
PMCPMC8622869
OpenAlexW3206428862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.